European Economic AreaNorthern IrelandREACH

EU Explores Restrictions On Harmful Chemicals 4-OPnEO And 4-NPnEO In Articles

The European Chemicals Agency (ECHA) is investigating the environmental risks of 4-OPnEO and 4-NPnEO due to their degradation into endocrine disruptors. Found in products such as paints and safety glass, these substances could face EU-wide restrictions to prevent emissions and protect the environment.

Published in December 2024. Dates, deadlines and stages may have changed since.

Dr Steven Brennan

3 min readAI-drafted, expert reviewed

Coatings

The European Chemicals Agency (ECHA) is assessing the risks of 4-OPnEO and 4-NPnEO, found in various articles like safety glass and coatings, due to their environmental hazards and potential to release harmful degradation products, with a decision on potential restrictions pending.

Environmental Concerns Over 4-OPnEO And 4-NPnEO

The substances 4-(1,1,3,3-tetramethylbutyl)phenol ethoxylated (4-OPnEO) and 4-Nonylphenol ethoxylated (4-NPnEO) are under scrutiny by ECHA. Used in paints, adhesives, and safety glass, these substances degrade into endocrine-disrupting chemicals, posing significant environmental risks. A recent report emphasised the inadequacy of current controls to prevent harmful emissions throughout the lifecycle of products containing these chemicals.

Key Findings From The Screening Report

ECHA's investigation highlights widespread usage and potential emissions:

Common Applications: Found in vehicles, plastics, construction materials, and medical device packaging.Environmental Emissions: Releases occur during usage and disposal, particularly in landfills, with potential contamination of soil and water.Degradation Risks: The degradation products—4-octylphenol and 4-nonylphenol—have no safe exposure thresholds, amplifying environmental concerns.

Regulatory And Industry Response

The EU’s Restrictions Roadmap may lead to broader controls on hydrocarbylphenols, the chemical family to which 4-OPnEO and 4-NPnEO belong. However, no final decisions have been made regarding a specific Annex XV dossier. Industry stakeholders have indicated challenges in replacing these substances in certain applications, citing technical and economic constraints.

Future Implications

ECHA underscores the necessity for EU-wide measures to harmonise environmental protection and ensure fair competition between European manufacturers and international importers. A comprehensive restriction could mitigate environmental damage while addressing disparities in global production standards.

The investigation reflects ECHA's commitment to evaluating and mitigating the risks posed by hazardous substances in consumer and industrial articles. The agency continues to seek input from stakeholders and remains focused on developing sustainable regulatory strategies.

Official source

echa.europa.eu

Topics

Questions about this change

What environmental risks are associated with 4-OPnEO and 4-NPnEO?

The environmental risks of 4-OPnEO and 4-NPnEO stem from their degradation into endocrine-disrupting chemicals like 4-octylphenol and 4-nonylphenol. These substances pose significant threats to ecosystems, as they have no safe exposure thresholds and can contaminate soil and water through emissions from products during use and disposal.

Why is the EU considering restrictions on 4-OPnEO and 4-NPnEO in consumer articles?

The EU is evaluating restrictions on 4-OPnEO and 4-NPnEO due to their harmful environmental impacts, especially in imported articles. Limiting these substances aims to harmonise environmental protection across the Union and ensure fair competition between European manufacturers and non-EU importers.

Dr Steven Brennan

CEO and co-founder of Foresight, and a co-opted member of ECHA's Committee for Socio-economic Analysis. He holds a PhD in chemical engineering.

More from Dr Steven Brennan

Join 3,500+ professionals staying ahead

Foresight Weekly brings the week's regulatory changes across chemicals, product safety, sustainability, ESG and EHS into one email.

Free. Unsubscribe at any time.

Read by professionals at

  • Boeing
  • AstraZeneca
  • Siemens
  • PepsiCo
  • SpaceX